Tilray was founded in 2013. It was originally incorporated under the umbrella of Seattle-based Privateer Holdings. Tilray became the first medical cannabis producer in North America to be GMP certified in December 2016. In July 2018 the company became the first cannabis company to IPO on the NASDAQ and trades under the ticket symbol TLRY. In September 2018, Tilray became the first Canadian cannabis company to legally export medical cannabis to the U. S. for a clinical trial. In December 2018, the company signed a deal with Novartis AG's subsidiary Sandoz generic pharmaceuticals to sell, distribute and co-brand Tilray's non-smokeable/non-combustible medical cannabis products in legal markets worldwide. On June 19, 2018, Tilray announced the launch of High Park Company which would operate in the adult recreational cannabis market to establish unique adult-use brands in Canada upon its legalization.